Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Kann Inspiration Mining die nächste 1.000 % Chance werden? Das Bohrprogramm startet in wenigen Tagen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40CR1 | ISIN: US42254E3027 | Ticker-Symbol:
NASDAQ
12.05.26 | 21:50
1,910 US-Dollar
-1,04 % -0,020
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
HEARTSCIENCES INC Chart 1 Jahr
5-Tage-Chart
HEARTSCIENCES INC 5-Tage-Chart

Aktuelle News zur HEARTSCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.05.HeartSciences Inc. - 8-K, Current Report-
05.05.HeartSciences Inc.: HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights148Southlake, TX, May 05, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing...
► Artikel lesen
14.04.HeartSciences Inc.: HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting1
03.04.HeartSciences Inc. - 8-K, Current Report-
25.03.HeartSciences Inc.: HeartSciences' MyoVista Insights Receives Epic Toolbox Designation for ECG Management System Category1
HEARTSCIENCES Aktie jetzt für 0€ handeln
17.03.Heart Test Laboratories GAAP EPS of -$0.63 beats by $0.191
16.03.HeartSciences Inc.: HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update189Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing...
► Artikel lesen
16.03.HeartSciences Inc. - 8-K, Current Report1
16.03.HeartSciences Inc. - 10-Q, Quarterly Report1
05.02.HeartSciences Inc.: University of West England Adopts HeartSciences' MyoVista Insights Platform and MyoVista wavECG Device to Establish ECG Education and Technology Reference Center1
29.01.HeartSciences Inc.: Cibolo Health Designates HeartSciences' MyoVista Insights as Endorsed ECG Management Platform for Network of 123 Independent Hospitals1
16.01.HeartSciences Inc. - 8-K, Current Report1
15.12.25HeartSciences Inc.: HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update1.387Southlake, TX, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography...
► Artikel lesen
15.12.25HeartSciences Inc. - 8-K, Current Report-
15.12.25HeartSciences Inc. - 10-Q, Quarterly Report-
15.12.25HeartSciences Inc.: HeartSciences Announces FDA 510(k) Submission for MyoVista wavECG Device2
11.12.25HeartSciences Inc.: HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1238Southlake, TX, Dec. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company advancing the use...
► Artikel lesen
28.11.25HeartSciences Inc. - 8-K, Current Report-
11.09.25HeartSciences Inc.: HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results344Southlake, TX, Sept. 11, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company...
► Artikel lesen
24.07.25HeartSciences Inc.: HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results647Southlake, TX, July 24, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company transforming...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1